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Genetic studies of autism spectrum disorder (ASD) have established that de novo duplications and deletions contribute to risk. However,
ascertainment of structural variants (SVs) has been restricted by the coarse resolution of current approaches. By applying a custom
pipeline for SV discovery, genotyping, and de novo assembly to genome sequencing of 235 subjects (71 affected individuals, 26 healthy
siblings, and their parents), we compiled an atlas of 29,719 SV loci (5,213/genome), comprising 11 different classes. We found a high
diversity of de novo mutations, the majority of which were undetectable by previous methods. In addition, we observed complex
mutation clusters where combinations of de novo SVs, nucleotide substitutions, and indels occurred as a single event. We estimate a
high rate of structural mutation in humans (20%) and propose that genetic risk for ASD is attributable to an elevated frequency of
gene-disrupting de novo SVs, but not an elevated rate of genome rearrangement.Introduction
Structural variants (SVs), such as deletions and duplica-
tions, are a major source of genetic differences between
humans and contribute significantly to risk of common
disease.1 In particular, studies of copy-number variation
(CNV) have been seminal in establishing a role for rare
genetic variants in the etiology of autism spectrum
disorder (ASD [MIM: 209850]).2,3 Despite this success,
characterization of SVs from individual genomes remains
a major challenge. Identification of SVs in human
populations and disease has been restricted by the
limited sensitivity of microarray- and sequencing-based
approaches.4–6
Large CNVs detectable by microarrays represent a small
fraction of structural variation in the genome. Recent
methodological advances have enabled the discovery of a
wide variety of SV classes from whole-genome sequencing
(WGS) datasets, including small deletions and duplications
down to 50 bp in length, inversions, translocations, mo-
bile-element insertions (MEIs), and more-complex rear-
rangements. By applying a combination of specialized
methods, each tailored to specific classes of variation, the
1000 Genomes (1000G) Project has produced the most
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(7.43) WGS in 2,504 human genomes.7 In a study of 250
population-control families, analysis of low-coverage
(133) WGS data allowed for detection of de novo dele-
tions, tandem duplications, and MEIs.8 However,
advanced analytical methods for SV discovery and geno-
typing have not been applied in genetic studies of ASD.
Initial forays into the application of WGS to the detection
of SVs in neurodevelopmental disorders have been
restricted to CNVs larger than 1 kb,9 focused on a subset
of variant calls prioritized by putative clinical rele-
vance,9,10 or limited to the characterization of CNVs previ-
ously detected by microarrays.6
More comprehensive ascertainment of SV is needed for
elucidating the genetic mechanisms that underlie ASD
risk. In this study, we applied a suite of complementary
SV-discovery methods, coupled with custom methods for
SV genotyping and detection of de novo mutations, to
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Discovery Institute, the Departments of Psychiatry,
Neurology, and Speech and Occupational Therapy, and
the Developmental Evaluation Clinic. Further referrals
came directly through our project website. The Autism
Center of Excellence at the University of California, San
Diego (UCSD), contributed a further 11 trios. Each child
included in the study has an existing ASD diagnosis and
received a diagnosis of ASD on the basis of an evaluation
by a licensed clinician.11 Prior to appointments, families
were provided with institutional-review-board-approved
consent forms and Health Insurance Portability and
Accountability consent forms. DNA was obtained from
5 ml blood draws. We recalled a subset of individuals
with specific genetic findings to confirm the original
ASD diagnoses. These included individuals with SVs
in TMEM185A (MIM: 300031), TESC (MIM: 611585),
NRXN1 (neurexin 1 [MIM: 600565]), and CACNG2
(MIM: 602911). A diagnosis of ASD was confirmed in all
affected individuals.
WGS
WGS was performed on 246 samples, which included 11
monozygotic twin pairs. One sibling from each twin
pair was excluded from the dataset, which brought the
final sample size to 235. WGS of 206 samples was per-
formed with an Illumina HiSeq at the Illumina Fast Track
service laboratory in San Diego. For 161 samples, prepara-
tions consisted of 313 bp libraries and 100 bp paired-end
reads. For the remaining 45 samples, library size and read
length were 493 and 125 bp, respectively. In addition, a
subset of our data consisted of 40 samples sequenced
with an Illumina HiSeq at the Beijing Genomics Institute
as described previously (SVs were not reported in this pub-
lication),12 and genomes were realigned to the human
reference genome (UCSC Genome Browser build hg19)
with the Burrows-Wheeler Aligner (BWA-mem version
0.7.12).13
To generate sequence alignment and variant calls on
families, we implemented our WGS analysis pipeline on
the Comet compute cluster at UCSD. Short reads were
mapped to the hg19 reference genome by BWA-mem
v.0.7.12.13 Subsequent processing was carried out with
SAMtools v.1.2,14 Genome Analysis Toolkit (GATK)
v.3.3,15 and Picard Tools v.1.129, which consisted of the
following steps: sorting andmerging of the BAMfiles, indel
realignment, removal of duplicate reads, and recalibration
of base quality scores for each individual.16
SV Detection
We utilized three complementary algorithms to detect SVs.
ForestSV is a statistical-learning approach that integrates a
wide variety of features, including signal from read depth
and discordant paired-ends, from WGS data to identify
deletions and duplications.17 Lumpy uses signal from
discordant paired ends and split reads to identify break-
points for deletions, duplications, inversions, translo-
cations, and complex SVs.18,19 Finally, Mobster uses signal668 The American Journal of Human Genetics 98, 667–679, April 7, 2from discordant paired ends and split reads in combina-
tion with consensus sequences of known active transpos-
able elements to identify MEIs.20
SV Post-processing
We assembled call sets of deletions, duplications, inver-
sions, complex SVs, and MEIs detected in 246 individuals.
For monozygotic twins, we generated a consensus call
set for each twin pair from the raw SV calls as an initial
processing step.
SV Filtering
SVs were filtered if they overlapped centromeres,
segmental duplications (genomicSuperDups), regions
with low mappability and 100 bp reads (wgEncodeCrg-
MapabilityAlign100-mer), and regions subject to somatic
V(D)J recombination (parts of antibodies and T cell re-
ceptor genes) by 50%. Genome annotations used for
filtering were downloaded from UCSC Genome Browser
build hg19. Filtered regions are provided in the Web
Resources.
ForestSV
ForestSV was run with default parameters. Large SVs that
were fragmented into multiple calls by ForestSV were
stitched together as a function of their separation distance
and divided by the total length of the individual calls. SVs
between individuals were collapsed on the basis of >50%
reciprocal overlap, and the same median start and end co-
ordinates were assigned to each call.
Lumpy
SVs were called within families according to the default
parameters of the SpeedSeq SV pipeline (v.0.0.3a), which
uses Lumpy (v.0.2.9) to process samples and SVtyper
(v.0.0.2) to genotype variants.18,19 The pipeline outputs
deletions, duplications, inversions, and breakpoints that
cannot be assigned to one of the three classes. To detect
complex SVs, we wrote a custom algorithm to cluster
overlapping pairs of breakpoints and resolve the patterns
and ordering of breakpoint alignments to the reference
genome. We detected five classes of complex SVs, both
intra- and interchromosomal. For intrachromosomal
events, if two or more sets of breakpoints overlapped
within an individual, we considered them to be part of
the same SV event, and then on the basis of the patterns
and orientations of discordant paired ends, we deter-
mined the SV type (as shown in Figure S3). For interchro-
mosomal duplications, we required that two or more sets
of breakpoints map to the same two chromosomes and
that at least one breakpoint from each set map within
one read length of each other (which restricted the size
of target-site duplications and deletions that we could
detect). Calls between individuals were considered to be
the same SV if they shared the same start and end coordi-
nates within a margin of error defined by the read length
(100 bp for most samples).016
Mobster
Mobile elements were called by Mobster v.0.1.6 within
families and were included in the call set if they had at least
five reads, including discordant paired ends at both the
30 and 50 sides of the insert point,20 supporting the call in
one individual in the family. The parameters used in the
Mobster properties file are available for download in the
Web Resources. Calls between individuals were considered
to be the same SV if they shared the same insertion coordi-
nates within a margin of error defined by the read length
(100 bp for most samples).
SV Genotyping and Calling of De Novo Mutations
We utilized gtCNV and SVtyper,18 two complementary
methods for assigning genotype likelihoods to SVs. Specif-
ically, gtCNV integrates signal from depth of coverage,
paired ends, and split reads and is most suitable for CNVs
(i.e., deletions or duplications). SVtyper does not use
coverage signal and therefore is more suitable for genotyp-
ing balanced SVs and the smallest (<500 bp) CNVs. We
used estimates of genotype likelihood to derive a quality
score for each SV site, defined as the median genotype like-
lihood for individuals genotyped as non-reference. We sys-
tematically genotyped a merged set of CNV calls (biallelic
deletions and duplications) from ForestSV and Lumpy.
CNVs that were called by both methods (i.e., overlapping
CNVs in the same individual) and had different break-
points were both genotyped, and the coordinates with
the best genotype likelihoods were retained in the SV call
set (Data S1). All 246 individuals were genotyped with
gtCNV for all CNVs called by the two algorithms.
We filtered the finalized call sets solely on quality scores
by using thresholds of 12 for deletions genotyped with
gtCNV, 8 for duplications genotyped with gtCNV, and
100 for SV breakpoints genotyped with SVtyper. The
false-discovery rate (FDR) of the combined call set was
estimated from Illumina 2.5M SNP array data with the in-
tensity-rank-sum (IRS) test implemented in the Structural
Variation Toolkit (see Web Resources).
From the finalized call set, we extracted de novo
mutations that had a non-reference genotype in the child,
reference genotypes in both parents, and a parent allele
frequency of 0 in the cohort.
gtCNV
To classify CNV genotypes, we developed gtCNV, a likeli-
hood-based support-vector-machine (SVM) approach that
genotypes deletions and duplications. The classifier was
trained on high-coverage CNV data from 27 individuals
sequenced as part of the 1000G Project.21
When training the SVM, we selected read depth, discor-
dant paired ends, and split reads as features. We extracted
features for all deletion and duplication calls made by
ForestSV and Lumpy. When determining coverage, we
masked regions overlapping segmental duplications. For
each SV, we calculated mean coverage, which we then
normalized to the mean chromosomal coverage for eachThe Amsample. We also extracted all discordant paired ends and
split reads (mapping quality > 20) by implementing the
SAMtools application programming interface for Python
in pysam.14 Discordant paired ends were defined as reads
with insert sizes more than 5 SDs from the mean.
The SVM training utilized a radial-basis-function (RBF)
kernel, which we implemented in Python by using scikit-
learn.22,23 In order to determine the optimal parameters
of the RBF kernel, we used the IRS test to estimate the
FDR for deletions and duplications in the call set. Optimal
parameters were C ¼ 1 and gamma ¼ 0.005, which had an
FDR of 7.0% for deletions at a quality score of R12. The
optimal parameters for duplications were C ¼ 1 and
gamma ¼ 0.01, which had an FDR of 9.2% at a quality
score ofR8. The gtCNV software can be found on GitHub
(see Web Resources), and the method will be further
detailed in a companion paper in the near future.
SVtyper
Genotyping of Lumpy calls was performed with SVtyper as
part of the SpeedSeq SV pipeline.18 SVtyper is a Bayesian
SV-breakpoint-genotyping algorithm that estimates the
likelihood that a genotype is non-reference on the basis
of allele counts at each junction. A quality score for each
individual SV locus was derived on the basis of the median
genotype likelihood for individuals genotyped as non-
reference. An optimal quality-score threshold for Lumpy
was determined as described in the section above. We per-
formed family-based calling and genotyping for Lumpy
calls and kept variants that had a median quality score R
100 across the cohort. For complex variants with multiple
overlapping breakpoints, we kept variants that had a me-
dian quality scoreR 100 for at least one breakpoint.
We assessed the performance of SVtyper by using the IRS
test described above. The FDR of CNV sites was 3.3% for
deletions, 9.5% for tandem duplications, 0% for deletions
in complex events, and 11.5% for duplications in complex
events (complex combined FDR ¼ 7.5%).
Sensitivity Analysis of CNVDetection andGenotyping
Pipeline
To assess the sensitivity of our CNV-calling pipeline, we
applied it to 27 samples sequenced with a high-coverage
PCR-free protocol in phase 3 of the 1000G Project. Raw
CNV calls from ForestSV and Lumpy were merged, geno-
typed, and then filtered as detailed above. Because our gen-
otyping method, gtCNV, was originally trained on these
data, we used a leave-one-out strategy to generate geno-
type likelihoods for calls in each sample (we excluded the
test sample from the training set before genotyping SV
calls in the sample). We then intersected our call set to
the non-reference deletions and biallelic duplications
found in the 1000G phase 3 SV call set for these 27 sam-
ples. Calls that had 50% reciprocal overlap with phase 3
CNVs were counted as overlapping within each sample.
Sensitivity values were then calculated and binned accord-
ing to CNV size (<100 bp, 100 bp to 1 kb, and >1 kb).erican Journal of Human Genetics 98, 667–679, April 7, 2016 669
Parent of Origin of De Novo SVs
For deletions, we extracted from the VCF file generated by
GATK HaplotypeCaller all SNPs that mapped within the
deletion breakpoints and that were homozygous alternate
(alt) in the proband, heterozygous in one parent, and ho-
mozygous reference in the other parent. The parental
origin was then inferred to be on the haplotype of the
parent who had homozygous reference alleles for informa-
tive SNP markers. For duplication CNVs, we extracted all
SNPs that mapped within the breakpoints and that were
heterozygous in the proband, had a ~2:1 ratio of reference
to alt alleles (or vice versa), and were heterozygous in one
parent and homozygous reference in the other parent. The
allele with double the expected number of reads indicates
which parental haplotype the duplication originated on.
In the case of the MEI in C3orf35 (chromosome 3 open
reading frame 35 [MIM: 611429]), we validated the MEI
(and flanking 30 UTR sequence) by cloning it into a vector
and sequencing it. The paternal origin was determined
from an informative variant within the cloned locus
(rs35484794).
From the exonic NRXN1 deletion, which is de novo in
the mother, we selected three SNPs (rs2042471,
rs12468395, and rs13031783) that were hemizygous in
the mother. SNPs were PCR amplified and Sanger
sequenced from the mother and grandparents. We further
performed paternity testing (DNA Solutions) of saliva and
confirmed that both grandparents are the biological
parents of the mother.
CNV Validation by SNP Microarray
We performed genome-wide assessment of CNVs in the
majority of individuals (n ¼ 205) in this study via Illumina
2.5M SNP microarrays. CNVs were detected by trio-based
calling implemented in the PennCNV algorithm24 and
were retained if they had at least eight supporting probes.
For de novo CNVs with fewer than eight probes, we as-
sessed the median log R ratio (LRR) of the probes within
the CNV locus for all individuals in the study and consid-
ered the CNV validated if the child’s median LRR was more
than 2 SDs below (for deletions) or above (for duplications)
the mean in the cohort.
PCR Validation of SVs
We designed PCR primers flanking breakpoints for small
CNVs, complex SVs, and balanced SVs. We attempted vali-
dation of nine putative de novo MEIs, six Alu insertions,
and three L1 insertions. For Alu elements, primers were de-
signed to flank the insertion point, and for L1 elements,
one primer was designed to flank the insertion point,
and two were designed within the element (both sense
and antisense because the orientations of the insertions
were unknown). Primers for SV validation are listed Table
S5. PCR amplification validated three de novo Alu ele-
ments when it was run on an agarose gel; the remaining
putative de novo variants were false positives. PCR prod-
ucts were cloned with TOPO-TA vectors. Resulting clones670 The American Journal of Human Genetics 98, 667–679, April 7, 2were screened and sequenced with M13 primers from
both ends of the vector insert. We assigned the subfamily
by using BLAST to compare the sequence results with the
consensus Alu sequences.
Assembly of Breakpoints
For deletion and duplication SVs, we used Velvet25 to
perform de novo assembly of clipped reads and determined
the precise breakpoint down to a single-base-pair resolu-
tion for 60.8% of deletions (n ¼ 11,168). We observed
that 17.9% of deletions had an inserted sequence at the
breakpoint. For duplications, we determined the break-
points for 31% (n ¼ 733). Breakpoint positions were as-
signed to SV coordinates where applicable in Data S1.
SV Burden
We assessed the burden of de novo SVs between ASD indi-
viduals in this study and the combined control individuals
from this study and a study from the Genome of the
Netherlands (GoNL) Consortium by using a case-control
permutation test implemented in PLINK.26
MEI Permutations
To permute the enrichment and/or depletion of MEI inser-
tions in genomic features, we used BedTools27 to shuffle
the position of the observed MEI sites across the genome
while maintaining the orientation of the MEI (sense or
antisense) but excluding any overlap with the filtered
regions above. We counted the number of times that a
shuffled MEI overlapped the following genomic features:
exons, introns (sense and antisense orientations sepa-
rately), promoters, 50 UTRs, and 30 UTRs. We performed
10,000 permutations and compared the observed overlap
to the expected overlap.
Overlap between SVs and Known Polymorphic SV
Events
Deletions, duplications, and inversions were intersected
with the 1000G SV call set with BedTools and were consid-
ered part of the same polymorphic or recurrent SV event if
they had >50% reciprocal overlap. MEIs were considered
to overlap if their insertion point was located within
100 bp of an MEI event of the same class from the
1000G integrated SV set or the database of retrotransposon
insertion polymorphisms.
Overlap between SVs and Published CNV Data
We permuted the expected overlap between SVs and CNV
regions (CNVRs) previously associated with ASD, intellec-
tual disability (ID), and developmental delay (derived
from two large-scale microarray CNV studies28,29). These
CNVRs are significantly more abundant in affected indi-
viduals than in control individuals and are either hotspots
flanked by segmental duplications or enrichment peaks
derived from the intersection of multiple breakpoints.
Using BedTools, we randomly shuffled the position of
the observed rare SVs in children (including SVs that016
are de novo or have a frequency < 1% in parents) while
maintaining the size of the CNVs and the chromosome
but excluding any overlap with sequencing gaps. We
counted the number of times that at least 90% of a shuf-
fled CNV overlapped a CNVR. When a single gene was
implicated by a CNVR, we stipulated that the CNV had
to overlap only one exon of the gene to be counted.
This method is conservative because it allows small
CNVs overlapping only a small proportion of larger
CNVRs to be counted, i.e., the overlap is not required
to be reciprocal.
When performing gene-set enrichment analysis with
published exome sequencing data, we determined the
number of SVs overlapping genes affected by one or
more loss-of-function SNVs and indels in studies of ASD
and ID, and we then permuted the SV positions while
maintaining the total number of genes disrupted.
Detection of De Novo SNVs and Indels
We called putative de novo SNVs by using ForestDNM,
a custom machine-learning pipeline that uses a random
forest classifier to predict the validation status of putative
de novo SNVs identified by the GATK UnifiedGenotyper.12
Putative denovo indelswere calledwith threedifferent algo-
rithms: GATK, Platypus, and Scalpel.15,30,31 First, we called
variants genome-wide by using GATK and Platypus. Then,
we used Scalpel for targeted de novo assembly of the locus
around this set of putative de novo indels. We kept de
novo indels called by at least two out of three algorithms.
We then excluded (1) any indels observed more than once
in the GATK or Platypus VCF files of the entire cohort and
(2) common indels in the population from 1000G data.
The genome-wide burden of de novo SNVs in case and con-
trol individuals was 66.9 and 63.3, respectively; for indels, it
was 6.67 and 6.11 for case and control individuals, respec-
tively. Analysis of de novo SNVs and indels will feature in
a future publication.
Mutational Clustering
To assess whether de novo SVs cluster with nucleotide sub-
stitutions or indels, we used a window-based permutation
approach. We took windows of 100 bp, 1 kb, 10 kb, 100 kb,
1 Mb, and 10 Mb around the breakpoints of de novo SVs
and intersected the windows with de novo SNVs and in-
dels in the same individuals. We then used BedTools to
shuffle the position of these windows in the genome either
randomly (excluding regions that were filtered during SV
calling) or across detected inherited SV breakpoints and
calculated the expected number of windows overlapping
DNMs by performing 100,000 permutations.
Transmission-Disequilibrium Test
Using a haplotype-based group-wise transmission-disequi-
librium test32 and assuming an additive model, we tested
whether variants private to families in our study and not
present in the 1000G call set were transmitted to affected
children more than expected by chance.The AmResults
Genome Sequencing Uncovers a Diverse Landscape of
Structural Variation
We recruited ASD-affected individuals and their families
(235 subjects, including 71 affected individuals and 26
typically developing siblings) from Rady Children’s Hospi-
tal, San Diego, and local pediatric clinics. WGS of blood-
derived genomic DNA was performed at a mean coverage
of 40.63 (Table S1 and Material and Methods).
We developed a SV-discovery pipeline that utilizes a com-
bination of three specialized methods each optimized to
capture a specific subtype of variation (Figure S1 andMate-
rial and Methods): (1) ForestSV17 is a statistical-learning
approach that we developed to integrate a variety of fea-
tures from WGS data into a random-forest classifier and is
optimized to detect deletions and duplications; (2)
Lumpy19 utilizes information from discordant paired ends
and split reads and is optimal for the detection of balanced
rearrangements, such as inversions and translocations; and
(3)Mobster20 utilizes discordant paired ends and split reads
to detectMEIs. Aswe have shownhere, this combination of
methods is highly efficient and provides accurate detection
ofmost known classes of SV. For each subject, unfiltered SV
calls from the three methods were merged into a set of
consensus calls (see Material and Methods).
The final call set from our 235 study subjects included
1,225,067 SVs (5,213 SVs/genome) from 29,719 sites
(Figure 1). The primary variant calls comprised seven ma-
jor classes, including deletions (3,383 alleles/individual;
18,359 sites), duplications (423 alleles/individual; 2,360
sites), inversions (51 alleles/individual; 211 sites), and
four classes of MEIs (1,105 alleles/individual; 7,915 sites)
(Figure 1, Data S1, and Table S2). FDRs for deletion and
duplication calls were estimated from Illumina 2.5M SNP
array data (with the Structural Variation Toolkit; see Mate-
rial and Methods), which were collected on a majority of
samples (n ¼ 205) in our study. The FDR was determined
to be 7.0% for deletions and 9.2% for duplications
(Figure S2). We assessed our sensitivity for detecting
deletions and biallelic duplications by applying our
methods to 27 individuals sequenced at high coverage in
the 1000G Project.21 We captured a majority (59%) of
SVs in the phase 3 call set. In addition, 40% of deletions
and 99% of duplications were unique to our call set
(Figure S2). The sensitivity for detecting 1000G phase 3 de-
letions was 75%, 61%, and 25% for lengths >1,000 bp,
100–1,000 bp, and <100 bp, respectively (Table S3).
The complete call set and detailed descriptive informa-
tion for all calls are provided in Data S1. A comparison of
our SV call set with the phase 3 SV call set from the
1000G Project is described in Figure S2.Detection of Complex Rearrangements
A recent study using a combination of microarrays and
sequencing of large-insert (‘‘jumping’’) libraries has shownerican Journal of Human Genetics 98, 667–679, April 7, 2016 671
de novo Figure 1. Structural Variation Detected
from WGS in 235 Individuals
Circos plot in which concentric circles
represent the following (from outermost
to inner): ideogram of the human genome
with colored karyotype bands (UCSC
Genome Browser build hg19), deletions,
MEIs (four different classes), tandem dupli-
cations, balanced inversions, and complex
SVs (four different classes). Circles indicate
the location of de novo SVs, and their
colors match the five SV types. Arrows
represent interchromosomal duplications.that a variety of complex SVs are observed in a subset
(24%) of ASD.6 In all subjects in our study, we identified
dense clusters of SVs with overlapping breakpoints. Most
of such instances could be resolved into one of four
‘‘complex’’ SV classes: tandem duplications with nested
deletions, non-tandem duplications, deletion-inversion-
deletion events, and duplication-inversion-duplication
events6 (Figure S3 and Table S4). Non-tandem duplications
were the most common form of complex SV (Table S4),
and these have not been documented in previous
genome-wide studies. Insertions occurred in direct and in-
verted orientations with equal probability, and 22% were
interchromosomal (Figure 1C [arrows] and Figure S4).
The majority (73%) had target-site deletions at the inser-
tion point. We detected an average of 251 complex SVs
per individual; thus, complex SVs represent common
forms of genetic variation in humans.
SV Genotyping and Detection of De Novo Mutations
Previous studies by our group and others found that de
novo SVs occur at significantly higher rates in ASD-affected
individuals than in typically developing offspring.2,4 The
more comprehensive SV dataset here provides an opportu-
nity to investigate de novo structural mutation with much
greater sensitivity. Identification of de novo SVs fromWGS
data, however, is a significant challenge. Given the ex-
pected number of false positives in our call set (>200/sub-
ject), the overwhelming majority of putative de novo672 The American Journal of Human Genetics 98, 667–679, April 7, 2016mutations will be errors.8 To address
this challenge, we performed joint
genotyping of SVs across all samples
by using gtCNV, a SVM-based algo-
rithm we developed here to estimate
genotype likelihoods for deletions
and duplications on the basis of mul-
tiple features including read depth,
discordant paired ends, and split
reads. Breakpoints called by Lumpy
were genotyped with SVtyper, which
performs Bayesian likelihood estima-
tion on the basis of the observed
discordant paired ends and split reads
at each junction.18 Putative de novo
SVs were validated by microarrayanalysis or through PCR and Sanger sequencing (Table
S5). We detected 31 de novo SVs and validated 19 in 97
offspring. De novo SVs consisted of a diversity of mutation
classes, including deletions (n ¼ 11), duplications (n ¼ 2),
inversions (n ¼ 1), Alu insertions (n ¼ 3), and complex SVs
(n ¼ 2; Table 1); their positions are indicated by circles in
the Circos plot in Figure 1. The overall FDR for de novo
SV calls was 39% (12/31). Compared to the 93% FDR
from a recent study by the GoNL Consortium,8 this repre-
sents a substantial improvement in the accuracy of calling
de novo SVs. Furthermore, 12 false-positive de novo muta-
tions in a call set of 29,719 SV sites represents a very low
error rate overall (0.04%).
High Rate of De Novo Structural Mutation in Humans
In this study, de novo SVs were observed in 19.7% of
affected individuals (95% confidence interval [CI] ¼
11.3%–32.2%) and 19.2% of control individuals (95%
CI¼ 7.3%–42.2%), a 3-fold and 10-fold higher rate, respec-
tively, than what was reported in previous studies of ASD
(Figure 2). The higher rate of de novo SV observed here is
driven by the fact that our methods have increased sensi-
tivity for detecting copy-neutral and smaller SVs. The
majority of de novo SVs (58% [11/19]) were undetectable
by a high-density (2.5M) SNP microarray (Figure S6).
Unlike in previous studies, the rate of de novo SVs was
not higher in affected individuals (Figure 2) than in control
individuals in this study (p ¼ 0.39) or than in a combined
Table 1. De Novo SVs
hg19 Coordinatesa Type Size (bp)b Locus Mechanism
Parental
Origin ID Status Gender
chr3: 37,476,966–37,476,979 AluYb8 14j134 C3orf35 (30 UTR) MEI paternal 74-0115-01 ASD female
chr13: 107,803,685–107,803,696 AluYa5 12j277 intergenic MEI NA REACH000120 ASD male
chr7: 112,115,899–112,123,778 complex 70j454j128 IFRD1, LSMEM1 MMBIR NA REACH000141 ASD male
chr14: 61,548,613–61,552,405 complex 23j140 SLC38A6 (intron 16/16) MMBIR paternal REACH000182 ASD male
chr2: 74,482,718–74,511,562 deletion 28,844 SLC4A5 (5/32 exons) MMBIR NA REACH000239 ASD male
chr6: 93,142,763–93,142,954 deletion 192 intergenic NHEJ NA REACH000001 ASD male
chr10: 69,823,502–69,823,806 deletion 305 HERC4 (intron 3/25) MMBIR NA REACH000288 ASD male
chr12: 117,519,631–117,537,968 deletion 18,338 TESC (1/8 exons) NHEJ paternal REACH000163 ASD male
chr13: 21,131,642–21,135,198 deletion 3,557 intergenic NAHR paternal REACH000292 ASD male
chr22: 36,969,581–37,097,776 deletion 128,195 CACNG2 (1/4 exons) NHEJ paternal REACH000001 ASD male
chrX: 148,682,301–148,736,750 deletion 54,450 TMEM185A (4/7 exons) NAHR maternal REACH000145 ASD male
chr15: 22,701,351–28,574,000 duplication 5,872,650 15q11.2–13.1 (PWS/AS)c NAHR maternal REACH000316 ASD female
chr20: 29,804,201–30,388,100 duplication 583,900 20q11.21 (18 genes) NAHR paternal REACH000141 ASD male
chr16: 60,410,404–61,926,470 inversion 1,516,067 CDH8 (9/12 exons) NHEJ NA L7H6W_01 ASD male
chr14: 58,985,087–58,985,102 AluYa5 16j312 KIAA0586 (intron 30/31) MEI NA REACH000176 control female
chr5: 111,391,882–111,398,120 deletion 6,238 intergenic NHEJ maternal REACH000300 control female
chr6: 100,911,772–100,916,248 deletion 4,476 SIM1 (upstream) NHEJ NA REACH000162 control male
chr12: 19,257,899-19,293,874 deletion 35,975 PLEKHA5 (3/35 exons) NHEJ maternal REACH000076 control female
chr12: 98,296,358–98,297,335 deletion 977 intergenic NHEJ NA REACH000236 control male
Abbreviations are as follows: AS, Angelman syndrome; ASD, autism spectrum disorder; NA, not available; MEI, mobile-element insertion; MMBIR, microhomol-
ogy-mediated break-induced replication; NAHR, non-allelic homologous recombination; NHEJ, non-homologous end joining; and PWS, Prader-Willi syndrome.
aCoordinates are based on breakpoint sequence alignments; however, coordinates for three NAHR-mediated SVs (15q11.2–13.3, 20q11.21, and Xq28) are based
on ForestSV boundaries.
bPipes (j) separate the sizes of individual elements within complex structural variants; further details can be found in Figure 4 and Table S5.
cCritical region for PWS and AS.set of 276 control trios from this study and a study from
the GoNL Consortium (p ¼ 0.17). Although the mutation
rate was not elevated in affected individuals, de novo SVs
were larger (median length of 10.9 and 1.2 kb in ASD
and control individuals, respectively; permutation p ¼
0.026), and a greater proportion of SVs intersected an
exon of at least one gene (11.1% and 2.8% in case and con-
trol individuals, respectively; permutation p ¼ 0.01).Figure 2. Frequency of De Novo SVs
A forest plot indicates the averagemutation frequency per genome
(m) from published microarray studies of ASD, from the ASD-
affected and control individuals in our study, and from a whole-
genome study from the GoNL Consortium. Error bars represent
the 95% CIs according to a Poisson distribution, and boxes are
proportional to the sample sizes tested.
The AmFine-Scale Characterization of De Novo SVs
Multilayered genetic information extracted from the
genome sequences of individuals can provide further
insights into the origin, mutational mechanism, and
functional impact of de novo SVs. For de novo events,
we assessed the parent of origin and the junction se-
quences obtained by local de novo assembly of break-
points. As an illustrative example, a de novo CACNG2
deletion detected in an individual is presented in Figure 3.
After detection of the deletion (Figure 3A) and genotype-
likelihood estimation of family members (Figure 3B), the
paternal origin of the deletion could be inferred from
allelic ratios of SNPs within the deleted region
(Figure 3C). The complete sequence of the breakpoint
junction could be assembled from reads that partially
mapped near the deletion boundaries (Figure 3D). From
the assembled breakpoint sequence, we inferred that
the deletion eliminates exon 2 and all but 634 bp of
intron 1 (Figure 3E) and that the deletion occurred by a
non-homologous end-joining mechanism.33 The mutant
transcript lacking exon 2 of CACNG2 was confirmed in a
fibroblast line derived from the individual and is







Figure 3. Detection, Genotyping, and Sequence Characterization of De Novo SVs
(A) Heatmaps show a deletion signal from the total sequence coverage (copy number) and the number of discordant paired ends.
(B) SVs were genotyped with gtCNV, a SVM algorithm we developed. The contour plot shows the Phred-scaled genotype likelihoods for
homozygous reference (green), heterozygous (blue), and homozygous (red) genotypes (for simplicity, only read depth and discordant
paired ends are plotted). The colored diamonds indicate the genotype likelihoods for the proband and the parents.
(C) A majority of SNP alleles between the deletion boundaries were derived from the mother (shown in black), confirming a deletion of
the paternal haplotype.
(D) De novo assembly of clipped reads resolved the breakpoint to single-base-pair resolution. Unaligned sequences within clipped reads
are highlighted in gray.
(E) Aligning the assembled contig to the genome revealed the deletion breakpoint. Unique sequence proximal and distal to the break-
point suggests a non-homologous-end-joining (NHEJ) mechanism.
(F) The mutant transcript of CACNG2 was sequenced from a fibroblast line derived from the individual and results in an in-frame dele-
tion of exon 2.acids of its extracellular AMPA receptor-binding domain
(Figure 3F).
MEIs, balanced SVs, and complex rearrangements have
not been systematically ascertained genome-wide in previ-
ous studies of ASD. Our results highlight how detection of
these SV classes is useful for gene identification. For
example, one validated MEI was a partial AluYb8 insertion
in the 30 UTR of C3orf35 (Figure 4A). This single observa-
tion was surprising given the low rate of de novo MEIs
and the strong depletion of MEIs within 30 UTRs in our674 The American Journal of Human Genetics 98, 667–679, April 7, 2call set (odds ratio [OR] ¼ 0.44; 95% CI ¼ 0.34–0.60;
Figure S7). Additionally, we identified a de novo inversion
(1.52 Mb) that disrupts cadherin-8 (CDH8 [MIM: 603008];
Figure 4B). These results strengthen the evidence from pre-
vious studies implicating C3orf354 and CDH834 in ASD.
Complex Mutation Clusters
The complexity of de novo SVs consisted not only of clus-
ters of deletions, duplications, and inversions occurring as





Figure 4. De Novo SVs of Genes Detect-
able through Genome Sequencing
Discordant paired-end mapping identified
de novo SVs.
(A) A de novo AluYb8 element insertion
into the 30 UTR of C3orf35. Discordant
paired ends and split reads mapped to
both the 30 and 50 sides of the insert point,
as well as the Alu. The partial AluYb8
(134 bp) was inserted into the positive
strand with a 14 bp target-site duplication
(shown in blue).
(B) A 1.52 Mb simple inversion with a
distal breakpoint in intron 3 of CDH8.
(C) A non-tandem duplication and a non-
tandem inverted duplication inserted into
the promoter of LSMEM1 with a concomi-
tant deletion at the insertion point (note
that segments are not shown to scale).
Arrows indicate the discordant orientation
and location of paired-end reads in rela-
tion to the reference genome (UCSC
Genome Browser build hg19) and the
concordant pattern of paired-end reads in
relation to the resolved structure. Black
segments are unchanged in the SV events,
green segments are inverted, blue seg-
ments are duplicated, and red segments
are deleted.nucleotide substitutions and indels in the surrounding re-
gion (Figure 5). We observed greater clustering of de novo
SVs and point mutations within individual genomes than
would be expected by chance. In total, six de novo muta-
tions (five SNVs and one indel) were located within
100 kb of de novo SV breakpoints, a 72-fold enrichment
over random mutation (permutation p ¼ 0.0001; Table
S6). Adjacent de novo SVs and SNVs were located tens of
kilobases apart; therefore, the enrichment of de novo sub-
stitutions around SV breakpoints could not be explained as
an artifact because of the mismapping of reads at the junc-
tion. An alternative hypothesis for the mutational clus-
tering is that the mutation rate of SNVs, indels, and SVs
is elevated within certain mutational hotspots. If this
were the case, we would expect de novo SNVs and indels
to also cluster near breakpoints of SVs that are inherited.
However, when we repeated the analysis, building a nullThe American Journal of Humamodel by shuffling the de novo SV
breakpoints across the inherited SV
breakpoints, instead of randomly,
gave us similar results (Table S6).
Figure 5 and Table S7 detail examples
of complex mutation clusters.
Pathogenic Inherited SVs
We examined the call set for known
pathogenic SVs and observed five
rare or de novo CNVs overlapping
known ASD or ID risk variants in
affected individuals (expected ¼ 2;
95% CI ¼ 0–5; p ¼ 0.063; OR ¼ 2.42).We did not observe significant overlap with genes affected
by de novo loss-of-function variants identified in ASD and
ID by exome sequencing (observed ¼ 13; expected ¼ 14.9;
95%CI¼ 8–23; p¼ 0.72; OR¼ 0.84). Inherited risk variants
were identified in four (6%) unrelated affected individuals.
One de novo SV identified in this study, a duplication of
15q11.2–13.1 (MIM: 608636; Table 1), has also been previ-
ously implicated in ASD.35 We observed two paternally in-
herited deletions of 15q11.2 (MIM: 615656).36 Inherited
X-linked variants included a Xp21.1–21.2 duplication-
inversion-duplication event that duplicates the Dp71 iso-
form of DMD (MIM: 300377) and disrupts TAB3 (MIM:
300480; Figure S3). Duplications and deletions of DMD
are associated with Duchenne muscular dystrophy, and
some alleles can predispose to ASD.36–38 Lastly, we detected
a maternally inherited deletion of NRXN1.36 Follow-up






Figure 5. Mutational Clustering of SVs, Indels, and SNVs
Two examples of complex mutation clusters are shown in individuals.
(A) REACH000182, a 143 bp sequence near the 30 UTR of SLC38A6, was duplicated and inserted into intron 16 of the gene with a
concomitant deletion of 23 bp at the insertion site. Additionally, a de novo indel and SNV occurred at 211 bp and 34,611 bp proximal
to the insertion site.
(B) REACH000300, a 6.2 kb de novo deletion, was detected at 5q22.2, and three de novo SNVs occurred within 100 kb of the breakpoints.
The 200 kb zoomed-in locus below the ideogram shows the positions of the de novo mutations in relation to each other. Gene tracks
below the mutation show the longest transcript of each gene within the locus (arrows indicate the strand, and bars indicate the exons
of genes).deletion occurred de novo in the mother and that the
mutation originated in the grandmother (Figure 6). This
observation highlights the fact that although these dis-
ease-associated variants were inherited from a parent,
they occur within regions that are prone to frequent recur-
rent rearrangements and are likely to be mutations that
occurred in recent ancestry.Discussion
Wehaveassembledwhat is, toourknowledge, themost com-
plete set of SVs in ASD to date.WGS of trio families reveals a
diverse landscape of structural variation throughout the
genome and a higher rate and complexity of structural mu-
tation than previously recognized. Structural mutations de-
tected in individuals include previously undetectable events
that disrupt genes and are likely to influence disease risk.
The combined frequencyof denovo SVs thatweobserved
(m¼ 0.195) is more than triple the estimate from a previous
WGS study of autism (m ¼ 0.058).9 Our estimate is also
slightly higher than the rate observed in a family-based
study by the GoNL Consortium (m ¼ 0.16).8 The mutation
rate reported here will ultimately prove to be an underesti-
mate as well given the challenges of detecting SVs by using
short-read next-generation sequencing technology.
With the improved ascertainment of small deletions, in-
versions, and MEIs, we observed a similar overall mutation
rate in case and control individuals, unlike in previous
studies by our group2 and others that were based onmicro-
array technology.29,39 Thus, a genetic contribution of de676 The American Journal of Human Genetics 98, 667–679, April 7, 2novo SVs to ASD is evident not from an elevated frequency
of genomic rearrangement but instead from the greater
proportion of new mutations that disrupt genes. In this
respect, the contribution of de novo structural mutation
to ASD bears a similarity to that of de novo loss-of-function
mutations detected by exome sequencing.40,41
Studies of genetic diversity in populations reveal a
diverse spectrum of SVs7 but do not fully illuminate the
mutational process that gives rise to that diversity. Here,
we have shown that one-third of de novo SVs consist of
mobile elements, balanced mutations, or complex muta-
tions, underlining the role that these mutational mecha-
nisms play in generating genetic diversity and disease
risk. Candidate loci for ASD were identified from two
such de novo SVs, including aMEI inC3orf35 and an inver-
sion disrupting CDH8. Published studies of ASD provide
additional evidence implicating both genes, including a
de novo deletion disrupting C3orf355 and segregating
CDH8 deletions observed in ASD-affected families.34
Our results highlight how clusters of SVs arise through
complex mutational events that generate combinations of
deletions, duplications, insertions, and inversions (and
sometimes all of the above). Adding further complexity to
the mutational process, we have shown that 16% (3/19) of
de novo SVs co-occur with clusters of de novo SNVs and in-
dels. These results expand upon our previous study report-
ing the observation of de novo nucleotide substitution
‘‘showers.’’12 Our current findings suggest that sequence
variation and structural variation can arise from common
mechanisms. We hypothesize that such complex mutation





Figure 6. Identification and Validation of
the Pathogenic NRXN1 Deletion
(A) A 166 kb deletion disrupting three
exons of NRXN1 leads to a frameshift in
the longer isoform (a-NRXN1).
(B) Breakpoint mapping shows a unique
sequence flanking the breakpoint, suggest-
ing a NHEJ mechanism.
(C) A forward PCR primer was designed
proximal to the breakpoint, and two
reverse primers were designed (one within
the deletion region produces a 302 bp
product, and one spanning the break-
points produces a 225 bp product in the
presence of a deletion). We confirmed the
deletion in this pedigree in the proband
(III-2) and mother (II-1), but not in the fa-
ther, sibling, or maternal grandparents.
(D) Pedigree of the family affected by
multiplex ASD. The NRXN1 deletion
occurred de novo in the mother and was
passed on to her younger son. The mother
is unaffected, and the older son has ASD
but did not inherit the deletion, suggesting
that other de novo and/or inherited vari-
ants contribute to ASD in this family.
(E) Sanger sequencing of rs2042471 within
the NRXN1 locus indicated that this dele-
tion originated on the grandmaternal
haplotype.(BIR) during the repair of double-stranded breaks. BIR is
significantlymore error prone thannormalDNA replication
and occurs over hundreds of kilobases,42 a scale that is
similar to the length of themutation clusters observed here.
The observation of complex mutation clusters is inter-
esting in light of a previous study from the 1000G Project,
which found that SNPs and indels in the population are
enriched within 400 kb of deletion breakpoints. It was
further hypothesized that the observed enrichment of
SNPs and indels is due to relaxed selection at these loci.43
On the basis of our results, we suggest that the observed
correlation between SNPs and SVs is in part attributable
to the underlying mutational processes and is not driven
entirely by selection.
With our high-coverage and complementary SV-discov-
ery methods, we were able to detect 5,213 SVs per individ-
ual, 27% more alleles per genome than we and others
recently reported in the 1000G call set (n ¼ 4,095/
genome).7 However, as we demonstrated (Figure S2), our
methods do not present a complete catalog of SVs. Further-
more, the short-read shotgun sequencing technology used
here possesses significant technical limitations that
impeded our ascertainment of SVs. Application of new
long-read sequencing technologies44 will be another sig-
nificant step toward uncovering the complexity of struc-
tural variation in autism.Supplemental Data
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